Plant lectins, from ancient sugar‐binding proteins to emerging anti‐cancer drugs in apoptosis and autophagy

Citations Over TimeTop 10% of 2014 papers

Abstract

Ubiquitously distributed in different plant species, plant lectins are highly diverse carbohydrate-binding proteins of non-immune origin. They have interesting pharmacological activities and currently are of great interest to thousands of people working on biomedical research in cancer-related problems. It has been widely accepted that plant lectins affect both apoptosis and autophagy by modulating representative signalling pathways involved in Bcl-2 family, caspase family, p53, PI3K/Akt, ERK, BNIP3, Ras-Raf and ATG families, in cancer. Plant lectins may have a role as potential new anti-tumour agents in cancer drug discovery. Thus, here we summarize these findings on pathway- involved plant lectins, to provide a comprehensive perspective for further elucidating their potential role as novel anti-cancer drugs, with respect to both apoptosis and autophagy in cancer pathogenesis, and future therapy.

Related Papers

• Roles of autophagy in lymphocytes： reflections and directions(2010)
• Death and survival of neuronal and astrocytic cells in ischemic brain injury： a role of autophagy(2011)
• Autophagy and cardiovascular diseases(2013)
• → Is Selective Autophagy Distinct from Starvation-Induced Autophagy?(2016)
• Autophagy in cancer biology and therapy(2014)